BioLife Solutions, Inc.
BLFS
$35.07
-$0.16-0.45%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 384.78% | 364.73% | -- | 136.47% | -- |
| Total Depreciation and Amortization | 52.07% | 37.06% | -- | -42.38% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -262.92% | -16.99% | -- | 31.87% | -- |
| Change in Net Operating Assets | -3,349.41% | -82.91% | -- | -144.20% | -- |
| Cash from Operations | -13.84% | -128.43% | -- | 27.11% | 14.07% |
| Capital Expenditure | 45.25% | 60.71% | -- | -137.40% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 98.58% | 93.78% | -- | -1,623.31% | -- |
| Cash from Investing | 96.01% | 93.27% | -- | -254.97% | -194.25% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 0.00% | -- | 7.89% | -- |
| Issuance of Common Stock | -83.33% | -- | -- | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 100.61% | -- | -103.56% | -- |
| Cash from Financing | -24.88% | -163.87% | -- | -145.73% | -308.81% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 103.35% | 64.08% | -- | -214.41% | -356.29% |